Register
Login:
Share:
Email Facebook Twitter

Add Gw Pharmaceuticals to quick picks

Gw Pharmaceuticals Share Price (GWP)



Share Price Information for Gw Pharmaceuticals (GWP)


Share Price: 431.00Bid: 431.00Ask: 432.50Change: 0.00 (0.00%)No Movement on Gw Pharm.
Spread: 1.50Spread as %: 0.35%Open: 431.00High: 444.25Low: 426.75Yesterday’s Close: 431.00
InfoGet Live Streaming Prices for GWP - Click here to start your 30 day FREE trial today.


Gw Pharmaceuticals Plc Ord 0.1P

Gw Pharmaceuticals is listed in the FTSE AIM 100, FTSE AIM UK 50, FTSE AIM All-Share
Gw Pharmaceuticals is part of the Pharmaceuticals & Biotechnology sector




Intraday Gw Pharmaceuticals Share Chart


Intraday Gw Pharmaceuticals Share Price Chart


Share Price SpacerPrice
431.00

Share Price SpacerBid
431.00

Share Price SpacerAsk
432.50

Share Price SpacerChange
0%0.00

Share Price SpacerVolume
251,265

Share Price SpacerOpen
431.00

Share Price SpacerHigh
444.25

Share Price SpacerLow
426.75

Share Price SpacerClose
431.00

Share Price SpacerCurrency
GBX

3 Month Gw Pharmaceuticals Share Graph


3 Month Gw Pharmaceuticals Share Price Graph


Currency Issue Country Shares in Issue Market Capitalisation Market Size
GBX GB 234.33m £1,009.97m 3,000

52 Week High 541.00 52 Week High Date 1-JUL-2014
52 Week Low 53.00 52 Week Low Date 12-AUG-2013

# Trades Vol. Sold Vol. Bought PE Ratio Earnings Dividend Yield
321 178,105 73,160 -143.667 -3.00 0.00 0.00




Date
Time
Trade Prc
Volume
Buy/Sell
Bid
Ask
Value
 

30-Jul-14
16:35:20
431.00
2,547
Sell* 
431.00
432.50
10.98k
UT 
Trade Type:
Uncrossing Trade

30-Jul-14
16:29:39
431.9991
2,000
Buy* 
430.50
432.00
8,640
Trade Type:
Ordinary
Bargain conditions apply

30-Jul-14
16:29:16
431.50
103
Buy* 
430.50
432.00
444.45
Trade Type:
Automatic execution


*Buys and Sells are calculated on the difference between the trade price and the current mid price. As such, they can occasionally be incorrect.

View more Gw Pharmaceuticals trades >>

Directors Deals for Gw Pharmaceuticals (GWP)
Trade DateActionNotifierPriceCurrencyAmountHolding
26-Nov-13Transfer To
Trade Notifier Information for GW Pharmaceuticals
Justin Gover held the position of Managing Director at GW Pharmaceuticals at the time of this trade.
 Justin Gover
0500,0003483368
30-Sep-13Notification of Holding
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
000
10-Jun-13Buy
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
0.1GBX7,50012500
View more Gw Pharmaceuticals directors dealings >>

Date/Time
Author
Subject
Share Price
Opinion
Wed 15:01
kingskin
RE: Next update
437.75
No Opinion

yay! we got there in the end :)
Wed 14:35
bifter
RE: Next update
440.25
No Opinion

According to this press release it's on the 6th. http://www.gwpharm.com/GW%20Pharmaceuticals%20to%20Report%20Q3%202014%20Financial%20Results%20%20and%20Host%20Conference%20Call%20on%206%20August%202014.aspx I think I'll set a buy to trigger above the high of the 5th. Either stock rises and I miss a few pence on a share when I enter. Or they plummet and I bag a bargain at a later date :)
Wed 13:21
kingskin
RE: 'Charlotte's Web'
433.00
No Opinion

I agree with the point that CW will not harm GW overall, but the idea pushed by cramer that docs will only prescribe fda approved drugs is a belief, its not a fact. docs have to currently prescribe CW, and they do. CW is being used in conjunction with MD's, including in a hospital. cant remember the type of trial they are doing, but they are doing some sort of trial - i don't think it is placebo controlled though. there is also the point that americans pay for treatment - insurance companies are likely to only pay for FDA approved drugs, BUT if you can grow your own then that point is taken out of the equation for at least some people. i have no info on the price of CW - just know they are non-profit, does not mean its free though.
Wed 12:05
FlowerPowerBob
RE: 'Charlotte's Web'
433.00
No Opinion

GW was the first company to get FDA approval for a drug derived from plant extracts. This means that Doctors will always look more favourably on a drug that has gone through proper rigorous trials and has a tight control process on how it grows, processes and extracts cannabis. I'm sure Charlotte's Web will do well - and it has a really good marketing angle but I think it won't harm GW too much.
Tue 20:01
kingskin
RE: 'Charlotte's Web'
426.00
No Opinion

another point though, the idea of oils may well become insignificant once hemp farmers catch up and sell their 'by-product' http://healing-with-hemp.com/hempjuice.php it will get cheaper when the supermarkets start selling it.
Tue 19:27
kingskin
RE: 'Charlotte's Web'
426.00
No Opinion

I was going to write a long response - but decided i could do it a shorter way, so.. FDA approval, epilodex will have it, CW wont. you can stop reading now ;) . we could discuss the Rolls Royce bit, and i could provide various links that could possibly dispute it to a degree, but ultimately GW have regulatory approval and CW or other botanical CBD products do not.(that is not to say that they are not fully tested though - CW is produced by a chemist (ex pfizer) and fully tested. GW do not need a law change, they just need FDA approval, but...the hype surrounding CW is palpable. CW does not work for all, neither does epilodex, CW currently has around 400 patients, epilodex have about 40. epilodex has a low specified THC content, so does CW -BUT some patients increase the THC in CW to get better results, not something they will do with epilodex IMO worldwide - GW will win, hands down. USA - I'm not so sure (with regard to epilepsy in the next few years)

Share prices shown are taken at time of message posting.
Thread ViewThread View
View more share chat for Gw Pharmaceuticals (GWP) >>
Please Login or Register to post messages

Share Trading BrochureRequest your Free brochures on share dealing, spread betting and CFDs

Gw Pharmaceuticals Plc Ord 0.1P home pageWebsite: Gw Pharmaceuticals Plc Ord 0.1P
Website Description: GW Pharmaceutical



Sign up for Live Prices


CD02WL.001.081313
Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.